Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders (Q40734999)
Jump to navigation
Jump to search
scientific article published on April 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders |
scientific article published on April 1, 1992 |
Statements
1 reference
Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders (English)
1 reference
1 reference
P. A. Engervall
G. T. Stiernstedt
G. C. Günther
1 April 1992
1 reference
1 reference
4
1 reference
2
1 reference
99-106
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference